Clinical trials recruiting for HER2 Low Breast Carcinoma
5
Recruiting trials
9
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALX148 | 1 |
| ARX788 | 1 |
| Amiloride | 1 |
| Elacestrant | 1 |
| Fam-Trastuzumab Deruxtecan-Nxki | 1 |
| Olaparib | 1 |
| Patritumab deruxtecan | 1 |
| SHR-A1811 for injection | 1 |
| TTX-MC138 | 1 |
| Trastuzumab deruxtecan | 1 |
| Tucatinib | 1 |
| Zanidatamab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Florida | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| Texas | 1 |
Top cities
Aurora, Colorado 1Birmingham, Alabama 1Boston, Massachusetts 1Chicago, Illinois 1Houston, Texas 1Minneapolis, Minnesota 1New Lenox, Illinois 1Orland Park, Illinois 1Phoenix, Arizona 1Rochester, Minnesota 1
Self-screener
Recruiting trials
- A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer
- ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
- Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd
- ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
- PRE-ISPY Phase I/II Oncology Platform Program
Related conditions
Trials recruiting for HER2 Low Breast Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Triple-negative breast cancer 138Metastatic breast cancer 131Hormone Receptor-positive Breast Cancer 24HER2-positive Metastatic Breast Cancer 8HER2-negative Breast Cancer 57Solid Tumor, Adult 38Solid Carcinoma 6Rectal Neoplasms 14Rectal cancer 152
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HER2 Low Breast Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.